News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. following a whistleblower complaint. The complaint alleges accounting irregularities that artificially inflated the company's financial results, specifically Adjusted EBITDA. This news led to a significant drop in Alignment Healthcare's stock …
This article provides key metrics for the ALHC5941479 bond issued by Alignment Healthcare, Inc. The bond has a 4.25% coupon rate and matures on November 15, 2029. Alignment Healthcare is described as a holding company that offers customized healthcare solutions, primarily Medicare Advantage plans, …
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (NASDAQ: ALHC) following allegations of "accounting irregularities" that "artificially inflated" the company's reported financial results. A whistleblower complaint claims that operating expenses were systematically misclassified as capital expenditures. This news …
Invesco Ltd. has reported beneficial ownership of 10,365,640 shares of Alignment Healthcare Inc. common stock, representing 5.0% of the outstanding class. The shares are held by clients of Invesco's advisory entities, with Invesco retaining sole voting power over 9,985,762 shares and sole dispositive power …
Glancy Prongay Wolke & Rotter LLP is continuing its investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) following allegations of federal securities law violations. This comes after a whistleblower lawsuit filed by a former executive claimed the company manipulated its finances by misclassifying operating expenses …
Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations after a whistleblower alleged "accounting irregularities" artificially inflated the company's financial results. The complaint claims millions in operating expenses were misclassified as capital expenditures, leading to a …
Shares of Alignment Healthcare (ALHC) dropped 16.7% following the announcement of a securities investigation by Kaplan Fox & Kilsheimer LLP. This investigation stems from a whistleblower complaint by a former executive alleging accounting irregularities, specifically the systematic misclassification of operating expenses as capital expenditures …
Alignment Healthcare has been upgraded from Hold to Buy following a significant valuation-driven price drop, despite strong Q2 operational performance including record-low medical benefits ratio and substantial membership and EBITDA growth. The company also raised its full-year guidance, with the stock currently trading at …
John E. Kao, CEO of Alignment Healthcare, sold 298,000 shares of company stock for over $4.1 million, executed under a Rule 10b5-1 trading plan. This sale comes as the stock trades near its 52-week low and after mixed Q2 2026 financial results, which included …
Alignment Healthcare (NASDAQ:ALHC) CEO John Kao sold 298,000 shares of the company's stock for approximately $4.14 million, reducing his direct ownership by 27.37%. This transaction occurred despite the company exceeding Q2 earnings expectations with $0.17 EPS and a 31.6% increase in revenue. Analysts maintain …
Kaplan Fox & Kilsheimer LLP has announced an investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) regarding potential securities law violations. This follows news of a whistleblower complaint alleging "accounting irregularities" that artificially inflated the company's financial results, specifically Adjusted EBITDA. Following this revelation, Alignment …
Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations. This follows a whistleblower complaint alleging "accounting irregularities" that "artificially inflated" the company's financial results and a key non-GAAP metric, Adjusted EBITDA. Following the news of the …
Pomerantz LLP is investigating potential securities fraud claims against Alignment Healthcare, Inc. (ALHC) following allegations by a former executive of "accounting irregularities." The whistleblower complaint suggests the company artificially inflated its financial results, including Adjusted EBITDA, by misclassifying operating expenses as capital expenditures. This …
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Alignment Healthcare, Inc. (ALHC) following allegations of accounting irregularities that artificially inflated the company's financial results. A former executive filed a whistleblower complaint, leading to a significant drop in Alignment's stock price on July …
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (NASDAQ: ALHC) after news emerged of a whistleblower complaint. The complaint alleges accounting irregularities that artificially inflated the company's financial results and executive compensation. Following this news, Alignment Healthcare's stock …
Lowey Dannenberg P.C. is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential federal securities law violations. This follows a whistleblower lawsuit alleging the company manipulated its finances by misclassifying operating expenses as capital expenditures to inflate its adjusted EBITDA. The lawsuit claims this artificial …
Hagens Berman Sobol Shapiro LLP has initiated an investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) following disappointing second-quarter 2026 financial guidance and serious whistleblower allegations. The investigation focuses on potential securities law violations, specifically concerning whether the company misled investors about profitability and expense …
Alignment Healthcare, Inc. (ALHC), a healthcare plans provider for seniors, shows potential for a 69% upside according to analyst ratings. Despite recent stock volatility and a bearish short-term technical outlook, the company boasts robust revenue growth and a strong return on equity. Its focus …
Alignment Healthcare (ALHC) is facing scrutiny due to a whistleblower lawsuit alleging misclassification of operating expenses, impacting its adjusted EBITDA. Despite a significant short-term stock price decline, a narrative suggests the company is 41.6% undervalued with a fair value of $24.92, based on aggressive …
JP Morgan has lowered its target price for ALIGNMENT HEALTHCARE INC from $26 to $22. This news was reported by Reuters on August 4, 2026. The article provides a brief update on the analyst rating change for the healthcare company.
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. following allegations of accounting irregularities that "artificially inflated" the company's financial results. A former executive filed a whistleblower complaint claiming millions in operating expenses were misclassified as capital expenditures, leading …
The provided content is a privacy consent page from Yahoo and does not contain any article text about Alignment Healthcare (ALHC). Therefore, it's impossible to summarize why the company might be ripe for a turnaround based on the given information. The content primarily focuses …
Raymond James downgraded Alignment Healthcare (NASDAQ:ALHC) to Outperform from Strong Buy and lowered its price target due to concerns about earnings visibility as the company expands into new markets. While Q2 2026 earnings beat expectations and the full-year guide was raised, increased investment spend …
Alignment Healthcare Inc. (ALHC) stock dropped significantly by 18.66% following a whistleblower lawsuit alleging the company misclassified $8–$10 million in expenses as capital expenditures to inflate Adjusted EBITDA. Several law firms have initiated investigations into potential securities law violations, posing material regulatory and governance …
Analysts from Bank of America Securities have issued bullish sentiments on three healthcare companies: Stryker (SYK), Alignment Healthcare (ALHC), and McKesson (MCK). Stryker received a Buy rating with a $380.59 price target, implying a 15.3% upside. Alignment Healthcare also garnered a Buy rating and …
Alignment Healthcare (ALHC) Stock Trades Down, Here Is Why What Happened? Shares of health insurance company Alignment Healthcare (NASDAQ:ALHC) fell 14.8% in the afternoon session after the company revealed plans to reinvest profits, which will lower its expected earnings for the second half of …
ALHC Q2 Deep Dive: Investments in Clinical Innovation and Member Growth Drive Mixed Market Response Health insurance company Alignment Healthcare (NASDAQ:ALHC) reported Q2 CY2026 results beating Wall Street's revenue expectations , with sales up 31.6% year on year to $1.34 billion. The company expects …
Alignment Healthcare (ALHC) experienced a significant stock drop despite showing improved Q2 2026 earnings, including a 32% revenue increase and better adjusted medical benefit and EBITDA margins. The market's reaction is attributed to ongoing legal risks, such as a whistleblower lawsuit and securities investigations, …
Vanguard Portfolio Management LLC has reported a significant stake in Alignment Healthcare Inc. (ALHC), holding 11,874,585 shares, which represents 5.74% of the outstanding common stock. This disclosure, made via a SCHEDULE 13G filing, indicates Vanguard has sole dispositive power over all these shares and …
Alignment Healthcare reported a significant 31.6% revenue increase to $1.34 billion in Q2 2026, exceeding analyst expectations. The company attributed this strong performance to its new AI-powered stratification model, which helps predict hospitalizations and optimize care. Alignment also raised its 2026 forecast, projecting membership …
Search by ticker symbol or company name and select a result to open its chart.